Publications by authors named "Anthony Durmowicz"

Claim this Profile
D
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities.
Dave P Nichols, Anthony G Durmowicz, Ann Field, Patrick A Flume, Donald R VanDevanter

Ann Am Thorac Soc· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CFTR modulator theratyping: Current status, gaps and future directions.
John Paul Clancy, Calvin U Cotton, Scott H Donaldson, George M Solomon, Donald R VanDevanter, Anthony G Durmowicz

J Cyst Fibros· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial.
Anthony G Durmowicz, Robert Lim, Hobart Rogers, Curtis J Rosebraugh, Badrul A Chowdhury

Ann Am Thorac Soc· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic fibrosis radiographic biomarkers - Commentary.
Anthony G Durmowicz

J Cyst Fibros· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic fibrosis biomarker - Commentary.
Anthony G Durmowicz

J Cyst Fibros· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CF end point commentary.
Anthony G Durmowicz

J Cyst Fibros· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiotropium Respimat Is Effective for the Treatment of Asthma at a Dose Lower Than That for Chronic Obstructive Pulmonary Disease.
Stacy J Chin, Anthony G Durmowicz, Badrul A Chowdhury

Ann Am Thorac Soc· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response.
Anthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, Badrul A Chowdhury

Chest· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience.
Anthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, Badrul A Chowdhury

Chest· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risks and benefits of indacaterol--the FDA's review.
Badrul A Chowdhury, Sally M Seymour, Theresa M Michele, Anthony G Durmowicz, Dongmei Liu

N Engl J Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duchenne muscular dystrophy: Drug development and regulatory considerations.
D Elizabeth McNeil, Carole Davis, Devanand Jillapalli, Shari Targum, Anthony Durmowicz

Muscle Nerve· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elastin insufficiency predisposes to elevated pulmonary circulatory pressures through changes in elastic artery structure.
Adrian Shifren, Anthony G Durmowicz, Russell H Knutsen, Gilles Faury, Robert P Mecham

J Appl Physiol (1985)· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elastin protein levels are a vital modifier affecting normal lung development and susceptibility to emphysema.
Adrian Shifren, Anthony G Durmowicz, Russell H Knutsen, Eiichi Hirano, Robert P Mecham

Am J Physiol Lung Cell Mol Physiol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis